Exhaled Breath Analysis in Human Subjects
- Conditions
- Exhaled Breath Pattern After Medication Intake, in OSA Patients, or Other Pulmonary Diseases
- Registration Number
- NCT05456009
- Lead Sponsor
- University of Zurich
- Brief Summary
Identification of exhaled breath pattern of human subjects
- Detailed Description
Breath analysis with mass spectormetry as a non-invasive method to identfy exhaled breath patterns.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1500
- >= 18 years
- Informed consent
- specific exclusion criteria for different subgroups
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Exhaled breath pattern baseline mass spectrometric profile of exhaled breath pattern of human subjects
- Secondary Outcome Measures
Name Time Method Chemical structure of exhaled breath molecules baseline The identification of the chemical structure of exhaled breath molecules
Distinguish between disease baseline The use of a breath print to distinguish between disease and/or health state
Medication baseline Response to medication and toxicity as a function of blood/breath drug concentrations
Excretion of drugs baseline Correlation between lung function and the excretion of drugs in exhaled breath
Disease marker baseline The correlation of a distinct disease marker with a breath print or breath feature
Body fluids baseline The correlations of identified molecules in exhaled breath with body fluids
Health state baseline The correlation of breath prints to subjective health state and/or quality of life
Trial Locations
- Locations (1)
University Hospital Zurich
🇨ðŸ‡Zürich, Zurich, Switzerland